Competing federal rulings spell trouble for abortion pill access


The legality of mifepristone, a key abortion drug, was called into question on Friday as a pair of competing rulings by federal judges has thrown a wrench into the pill's availability.
Texas-based U.S. District Judge Matthew Kacsmaryk, an appointee of former President Donald Trump, ruled that the Food and Drug Administration (FDA) had violated a federal rule allowing fast-tracked approval for certain drugs, and suspended the FDA's authorization of mifepristone. However, he noted in his opinion that the Biden administration had seven days to appeal his verdict.
However, just minutes later, Washington state-based U.S. District Judge Thomas O. Rice, appointed by former President Barack Obama, issued a ruling directly contradicting Kacsmaryk's verdict, in a case brought by 17 states seeking to stop the FDA from pulling mifepristone. Rice ordered the FDA not to make any changes to the drug's approval, and NPR noted that his ruling blocked the agency from "altering the status quo and rights as it relates to the availability of mifepristone."
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Washington state Attorney General Bob Ferguson told NPR that Rice's ruling could allow patients in those 17 states to keep using mifepristone in the short term, even if Kacsmaryk's opinion is enacted.
"If you live in Washington State or one of the 17 states that joined Washington in our lawsuit...then the judge's ruling in our case preserves the status quo on ensuring that access to mifepristone remains available," Ferguson said. He added, though, that for people not in one of those 17 states, Kacsmaryk's decision "seriously has the potential to eliminate that access for mifepristone here in the coming days."
The Biden administration has already appealed Kacsmaryk's verdict, and USA Today reported that the situation seems destined for argument before the nation's Supreme Court justices, which could further limit abortion access following the rollback of Roe v. Wade.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Justin Klawans has worked as a staff writer at The Week since 2022. He began his career covering local news before joining Newsweek as a breaking news reporter, where he wrote about politics, national and global affairs, business, crime, sports, film, television and other news. Justin has also freelanced for outlets including Collider and United Press International.
-
Columbia pays $200M to settle with White House
Speed Read The Trump administration accused the school of failing to protect its Jewish students amid pro-Palestinian protests
-
Florida judge and DOJ make Epstein trouble for Trump
Speed Read The Trump administration's request to release grand jury transcripts from the Epstein investigation was denied
-
Trump attacks Obama as Epstein furor mounts
Speed Read The Trump administration accused the Obama administration of 'treasonous' behavior during the 2016 election
-
Trump administration releases MLK files
Speed Read Newly released documents on the 1968 assassination of the Rev. Dr. Martin Luther King Jr. did not hold any new revelations, King historians said
-
Japan's prime minister feels pressure after election losses
Speed Read Shigeru Ishiba has vowed to remain in office
-
Gavin Newsom mulls California redistricting to counter Texas gerrymandering
TALKING POINTS A controversial plan has become a major flashpoint among Democrats struggling for traction in the Trump era
-
President diagnosed with 'chronic venous insufficiency'
Speed Read The vein disorder has given Trump swollen ankles and visible bruising on his hands
-
'Bawdy' Trump letter supercharges Epstein scandal
Speed Read The Wall Street Journal published details of Trump's alleged birthday letter to Epstein